AD mouse models are created using transgenic, knock-in, and injection methods, focusing on Aβ pathology (PDAPP, Tg2576, and APP23), tau, and neuroinflammation (JNPL3, rTg4510, PS19, and 3xTg)419. The gene discussed is MAPT; the disease is Alzheimer disease.